Mucinex® for Treatment of Filamentary Keratitis

Completed · Not applicable

Conditions studied: Filamentary Keratitis

In brief

It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.

Key facts

Study ID

NCT02859246

Run by

Massachusetts Eye and Ear Infirmary

People needed

15

Starts

2016-09-01

Expected to finish

2018-07-01

Last updated by the study team

2020-02-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with filamentary keratitis
• 18 years and older

You may not qualify if…

• Active ocular surface infection of any type
• Recent ocular surgery (<30 days) history of nephrolithiasis as Mucinex® has been associated in rare cases of development of kidney stones
• Schirmer's test<3mm
• History of hypersensitivity to Mucinex®
• Concurrent eye disease requiring immediate initiation of a new treatment (e.g. topical steroids) restriction for water intake can exacerbate the risk of nephrolithiasis.

Where it is running

• Massachusetts Eye and Ear Infirmary — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.